Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Caribou Biosciences (CRBU) Other Gross PP&E Adjustments (2020 - 2025)

Caribou Biosciences has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$4.0 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 165.07% to -$4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Dec 2025, down 165.07% year-over-year, with the annual reading at -$4.0 million for FY2025, 165.07% down from the prior year.
  • Other Gross PP&E Adjustments was -$4.0 million for Q4 2025 at Caribou Biosciences, down from $4.5 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $13.0 million in Q1 2025 and troughed at -$15.3 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $4.0 million (2025), against an average of $1.2 million.
  • Year-over-year, Other Gross PP&E Adjustments tumbled 296.31% in 2022 and then soared 1088.96% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $8.4 million in 2021, then plummeted by 229.04% to -$10.8 million in 2022, then skyrocketed by 105.61% to $607000.0 in 2023, then soared by 918.29% to $6.2 million in 2024, then crashed by 165.07% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Other Gross PP&E Adjustments are -$4.0 million (Q4 2025), $4.5 million (Q3 2025), and $4.0 million (Q2 2025).